CAME 已经真正成为美妆行业创新与合作的核心平台

美国个人护理产品协会（PCPC）全球策略副总裁：

在2025中国香料香精化妆品工业年会暨精品博览会（2025CAME）期间，中国香料香精化妆品工业协会（CAFFCI）国际事务部书面专访了美国个人护理产品协会（PCPC）全球策略副总裁 Natalie Obermann。

以下是书面专访的内容：

Q: This is your second time at CAME. What are your impressions of this year’s event?

问：这是您第二次参加CAME，您对今年的大会有何印象？

A: CAME has grown tremendously. The scale, energy and international reach in Nanjing are striking. Compared with last year, the global engagement and depth of technical dialogue stood out. It’s become a true hub for innovation and collaboration in the beauty industry.

答：CAME 发展得非常迅速。今年在南京的规模、活力和国际影响力都令人印象深刻。与去年相比，今年的国际参与度和技术交流的深度尤为突出。CAME 已经真正成为美妆行业创新与合作的核心平台。

Q: As a recipient of the “International Friendly Collaboration Partner” Award, could you share your reflections?

问：作为“国际友好合作伙伴”奖牌的获得者，您能分享一下感言吗？

A: I’m deeply honored to receive this award on behalf of PCPC. This award reflects the trust and collaboration between the association and CAFFCI. It’s a testament to our shared commitment to advancing the beauty industry together.

答：我非常荣幸能代表PCPC 获得这一奖项。这一荣誉体现了 PCPC 与中国香妆协会之间的信任与合作，也证明了我们共同致力于推动美妆行业发展的承诺。

Q: What is PCPC’s mission, and what recent achievements stand out?

问：PCPC 的使命是什么？近期有哪些突出的成就？

A: Our mission is to champion safety, science and innovation in the beauty industry. The U.S. passage of the Modernization of Cosmetics Regulation Act was a truly bipartisan effort that brought together a diverse group of stakeholders, including PCPC and our member companies, who worked diligently to advance science-based reforms. PCPC believes it is important to prioritize the continued implementation of MoCRA, the approval of new sunscreen filters and the validation of non-animal testing approaches for cosmetics and personal care products development—with strong support for the Humane Cosmetics Act. These critical actions help meet the evolving needs of consumers and increase confidence in the safety of our products.

答：我们的使命是推动美妆行业的安全、科学与创新。在美国，《化妆品监管现代化法案》（MoCRA）的通过是一次真正跨党派的努力，汇聚了包括 PCPC 和我们的会员企业在内的多方利益相关者，共同推动基于科学的改革。PCPC 认为，未来的重点在于继续推进 MoCRA 的落实、新防晒剂过滤成分的批准，以及化妆品和个护产品非动物替代试验方法的验证，并积极支持《人道化妆品法案》。这些关键举措既能满足消费者不断变化的需求，也能增强公众对产品安全的信心。

Q: How well prepared are U.S. SMEs for MoCRA, and how has PCPC supported them?

问：美国中小企业在应对MoCRA 方面准备得如何？PCPC 在这方面做了哪些支持？

A: MoCRA largely codifies existing industry best practices, reinforcing the beauty industry’s dedication to science-based safety and accountability. PCPC continues to support industry with navigating compliance, ensuring broad industry alignment and consumer protection. We’ve equipped SMEs with multiple resources, such as toolkits, webinars and one-on-one support from our experts. We also maintain active dialogue with FDA to support clear, timely guidance, especially on fragrance allergen disclosure and Good Manufacturing Practice standards. As a result, many SMEs are actively working to meet MoCRA deadlines, including product listing and safety substantiation.

答：MoCRA 在很大程度上将行业既有的最佳实践法律化，强化了行业对科学、安全和责任的承诺。PCPC 持续为行业提供合规指引，确保整体一致性和消费者保护。我们为中小企业提供了多种资源支持，包括工具包、网络研讨会，以及专家一对一指导。同时，我们也与 FDA 保持积极对话，推动清晰、及时的指导出台，尤其是在香料过敏原披露和 GMP（良好生产规范）标准方面。因此，目前许多中小企业正积极努力，按照 MoCRA 的要求完成产品目录登记和安全性证实等工作。

Q: What suggestions would you offer on managing new cosmetic ingredients in China?

问：您对中国化妆品新原料管理有哪些建议？

A: China’s surge in new ingredient filings is encouraging. We see an opportunity to streamline the regulatory process so it reflects the low-risk nature of cosmetics, rather than treating them like pharmaceuticals. That’s why PCPC has been engaging closely through joint webinars with NIFDC focused on INCI. Getting ingredient names right may sound like a small detail, but it’s essential for consistent and accurate substance identification. We want to ensure that new ingredients are filed under the correct INCI names, and we stand ready to support Chinese authorities as a trusted partner in advancing the INCI process to promote harmonization and consistency across global markets. Another step is embracing modern, non-animal testing methods that are already scientifically validated will further support innovation while ensuring consumer safety. PCPC members are eager to continue technical exchanges with CAFFCI and NMPA.

答：中国新原料备案数量的快速增长令人鼓舞。我们认为，可以进一步简化监管流程，以更符合化妆品低风险属性，而不是将其视同药品进行管理。正因如此，PCPC 一直与中国 NIFDC 通过联合研讨会保持密切互动，聚焦于 INCI（国际化妆品原料名称）。原料名称看似细节，但它对于一致且准确的物质识别至关重要。我们希望确保新原料能够按照正确的 INCI 名称备案，并愿意作为值得信赖的合作伙伴，全力支持中国监管部门推进 INCI 工作，促进全球市场的协调和一致性。另外，广泛采用已通过科学验证的现代非动物替代试验方法，也将进一步推动创新，同时保障消费者安全。PCPC 的成员企业非常期待继续与 CAFFCI 以及 NMPA 在技术层面开展深入交流。

Q: In PCPC’s global strategy, what role does China play, and what future cooperation might there be with CAFFCI?

问：在PCPC 的全球战略中，中国扮演怎样的角色？未来与 CAFFCI 有哪些合作设想？

A: China is a cornerstone of the global cosmetics market. PCPC values our partnership with CAFFCI, from INCI translation to regulatory collaboration. Looking ahead, we’d welcome a U.S.–China cosmetics dialogue to share best practices, advance regulatory modernization, and build consumer trust in safe, sustainable and cruelty-free products.

答：中国是全球化妆品市场的核心。PCPC 非常重视与 CAFFCI 的合作，从 INCI 翻译到法规合作，成果都非常积极。展望未来，我们非常期待建立中美化妆品对话机制，分享最佳实践，推动监管现代化，增强消费者对安全、可持续和无动物实验产品的信任。

2025年10月09日 08:59